Tackling The Standardization Issue For mRNA Therapeutics

The lack of standardization across mRNA therapeutics can make it difficult to compare processes and results across different studies and companies. Here, Joseph Barberio, VP Technical Operations at Strand Therapeutics and Christian Moreno, Director of Supply Chain Management at Nutcracker Therapeutics share obstacles to establishing a standardized production pipeline for mRNA therapeutics across the industry as well as some the approaches being considered to standardize cold chain management protocols for mRNA products.